Strategies for Optimized Radiolabeling of Nanoparticles for in vivo PET Imaging
Source abstract
Abstract
A new strategy to construct shell crosslinked nanoparticles has been developed, containing large numbers of effective DOTAlysines per particle (> 400) for 64Cu radiolabeling. These 64Cu-complexed nanoparticles show impressive specific activities (ca. 400 μCi μg–1), which suggests that they will serve as highly sensitive in vivo PET tracers at low administering doses.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Radiopharmaceutical Chemistry and Applications · Medical Imaging Techniques and Applications · Mass Spectrometry Techniques and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. 10.1073/pnas.97.16.922610.1073/pnas.97.16.9226 ↗
2. 10.1148/radiology.219.2.r01ma1931610.1148/radiology.219.2.r01ma19316 ↗
3. 10.1038/nrc88210.1038/nrc882 ↗
4. 10.1038/nrd103710.1038/nrd1037 ↗
5. 10.1038/nrc136810.1038/nrc1368 ↗
6. 10.2174/15680260577429705610.2174/156802605774297056 ↗
7. Weber W. A. · J. Nucl. Med. · 2006 · 47 · 735
8. 10.1177/009127000141700910.1177/0091270001417009 ↗
9. 10.1007/s00259-001-0683-310.1007/s00259-001-0683-3 ↗
10. 10.1002/jcb.1041710.1002/jcb.10417 ↗
11. 10.1007/s00259-004-1683-x10.1007/s00259-004-1683-x ↗
12. 10.1200/JCO.2004.10.21610.1200/JCO.2004.10.216 ↗
13. 10.1007/s00702-004-0272-210.1007/s00702-004-0272-2 ↗
14. 10.1080/0265673060078467710.1080/02656730600784677 ↗
15. Cherry S. R. · J. Nucl. Med. · 2006 · 47 · 1735
16. 10.1021/cr980451q10.1021/cr980451q ↗
17. 10.1109/TNS.2002.80368510.1109/TNS.2002.803685 ↗
18. 10.1016/j.jinorgbio.2004.06.00910.1016/j.jinorgbio.2004.06.009 ↗
19. 10.2174/13816120777931376810.2174/138161207779313768 ↗
20. 10.1021/jm030383m10.1021/jm030383m ↗
21. 10.1016/S0169-409X(98)00100-810.1016/S0169-409X(98)00100-8 ↗
22. 10.1016/S0169-409X(02)00019-410.1016/S0169-409X(02)00019-4 ↗
23. 10.1016/S0169-409X(02)00044-310.1016/S0169-409X(02)00044-3 ↗
24. 10.1016/j.addr.2003.12.00410.1016/j.addr.2003.12.004 ↗
25. 10.1016/j.addr.2004.02.01410.1016/j.addr.2004.02.014 ↗
26. Rossin R. · J. Nucl. Med. · 2005 · 46 · 1210
27. 10.1021/bm050260e10.1021/bm050260e ↗
28. 10.1002/jcb.1042210.1002/jcb.10422 ↗
29. 10.2174/13816120677902631710.2174/138161206779026317 ↗
30. 10.1002/(SICI)1099-0518(20000501)38:9<1397::AID-POLA1>3.0.CO;2-N10.1002/(SICI)1099-0518(20000501)38:9<1397::AID-POLA1>3.0.CO;2-N ↗
31. Y. Li G. Sun J. Xu K. L. Wooley inNanotechnology in Therapeutics: Current Technology and Applications (Eds: N. A. Peppas J. Z. Hilt J. B. Thomas) Horizon Bioscience Norfolk U. K.2007 Ch. 16.
32. 10.1021/ma070267j10.1021/ma070267j ↗
33. 10.1021/bm049551y10.1021/bm049551y ↗
34. 10.1021/ja971052010.1021/ja9710520 ↗
35. 10.1021/ja971746910.1021/ja9717469 ↗
36. 10.1126/science.268.5218.172810.1126/science.268.5218.1728 ↗
37. 10.1021/ja953709s10.1021/ja953709s ↗
38. 10.1039/b100819f10.1039/b100819f ↗
39. 10.1002/hlca.1986069083010.1002/hlca.19860690830 ↗
40. 10.1021/la053199810.1021/la0531998 ↗
41. 10.1021/cm051047s10.1021/cm051047s ↗
42. 10.1016/S0969-8051(96)00157-610.1016/S0969-8051(96)00157-6 ↗